Literature DB >> 8673484

Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI.

J W Thorpe1, D Kidd, I F Moseley, A J Thompson, D G MacManus, D A Compston, W I McDonald, D H Miller.   

Abstract

Although MRI detects the white matter lesions of multiple sclerosis within the brain with high sensitivity, a minority of patients have normal brain MRI. We describe 20 patients, selected from over 170 who had undergone brain imaging with minimal (n = 12) or no (n = 8) abnormalities (median number of lesions = I, range, 0-3) but in whom spinal MRI was abnormal. Twelve had clinically definite or laboratory supported definite multiple sclerosis according to the Poser criteria; one had clinically probable disease and seven, not fulfilling the Poser criteria, were classified as possible multiple sclerosis. All had presented with symptoms and signs referable to the spinal cord or optic nerves. Eleven had a primary progressive course, eight relapsing-remitting and only one secondary progressive. Moderate or severe disability was the rule in the primary progressive cases; all the relapsing-remitting patients had minimal disability. All had at least one lesion visible in the spinal cord (median 2; range 1-6). In patients in whom the diagnosis of multiple sclerosis is not supported by abnormalities on brain MRI, imaging of the spinal cord can be of considerable value.

Entities:  

Mesh:

Year:  1996        PMID: 8673484     DOI: 10.1093/brain/119.3.709

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  26 in total

1.  Making the diagnosis of multiple sclerosis.

Authors:  J Palace
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-12       Impact factor: 10.154

Review 2.  Clinical trials and clinical practice in multiple sclerosis: conventional and emerging magnetic resonance imaging technologies.

Authors:  Massimo Filippi; Maria A Rocca; Marco Rovaris
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

3.  Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis.

Authors:  R J Butterfield; E P Blankenhorn; R J Roper; J F Zachary; R W Doerge; C Teuscher
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 4.  Mechanisms regulating regional localization of inflammation during CNS autoimmunity.

Authors:  Emily Pierson; Sarah B Simmons; Luca Castelli; Joan M Goverman
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

5.  Cervical spinal cord multiple sclerosis: evaluation with 2D multi-echo recombined gradient echo MR imaging.

Authors:  Matthew L White; Yan Zhang; Kathleen Healey
Journal:  J Spinal Cord Med       Date:  2011       Impact factor: 1.985

Review 6.  [Inflammatory diseases of the spinal column and the myelon].

Authors:  F J Ahlhelm; J M Lieb; S Ulmer; T Sprenger; C Stippich; J Kelm
Journal:  Radiologe       Date:  2011-09       Impact factor: 0.635

7.  Thoracic spinal cord lesions are influenced by the degree of cervical spine involvement in multiple sclerosis.

Authors:  L H Hua; S L Donlon; M J Sobhanian; S M Portner; D T Okuda
Journal:  Spinal Cord       Date:  2015-01-13       Impact factor: 2.772

8.  Criteria improving multiple sclerosis diagnosis at the first MRI.

Authors:  Nathalie Caucheteux; Adil Maarouf; Margaux Genevray; Emmanuelle Leray; Romain Deschamps; Marie P Chaunu; Laure Daelman; Jean C Ferré; Olivier Gout; Jean Pelletier; Laurent Pierot; Gilles Edan; Ayman Tourbah
Journal:  J Neurol       Date:  2015-02-17       Impact factor: 4.849

9.  Expression of beta2 adrenoreceptors on peripheral blood mononuclear cells in patients with primary and secondary progressive multiple sclerosis: a longitudinal six month study.

Authors:  Y Zoukos; T N Thomaides; D Kidd; M L Cuzner; A Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

Review 10.  Cutting-edge imaging of the spine.

Authors:  A Talia Vertinsky; Michael V Krasnokutsky; Michael Augustin; Roland Bammer
Journal:  Neuroimaging Clin N Am       Date:  2007-02       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.